Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study
Summary
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Arms & interventions
- Drug64Cu-SAR-bisPSMA
All Patients will receive a single administration, a bolus injection of 200MBq 64Cu-SAR-bisPSMA.
Outcome measures
Primary
Diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases
Independent primary endpoints for Day 1 and Day 2 PET: Co-primary endpoint of sensitivity and specificity of 64Cu-SAR-bisPSMA PET to detect Prostate Cancer within the pelvic lymph nodes compared to the Standard of Truth.
Time frame: Up to 16 weeks
Secondary
Safety and tolerability of 64Cu-SAR-bisPSMA
Time frame: Up to 16 weeks
Consistency of 64Cu-SAR-bisPSMA PET/CT interpretations for the three central readers
Time frame: Up to 16 weeks
PPV and NPV of 64Cu-SAR-bisPSMA PET to detect PC within the pelvic LNs
Time frame: Up to 16 weeks
Ability of 64Cu-SAR-bisPSMA PET to detect Prostate Cancer
Time frame: Up to 16 weeks
Diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases without subregion matching
Time frame: Up to 16 weeks
Eligibility criteria
Study locations (27)
University of Alabama Birmingham Hospital
Birmingham, Alabama, 35249-6830
Mayo Clinic- Phoenix
Phoenix, Arizona, 85054
Arkansas Urology Research Center, LLC
Little Rock, Arkansas, 72211
Urology Group of Southern California
Los Angeles, California, 90017
Greater Los Angeles VA Medical Center
Los Angeles, California, 90073
UC Irvine Health
Orange, California, 92868
Stanford University Medical Center
Stanford, California, 94305-5105
Mayo Clinic- Jacksonville
Jacksonville, Florida, 32224
Biogenix Molecular, LLC
Miami, Florida, 33165
NorthShore University Health System, Glenbrook Hospital
Glenview, Illinois, 60026
Indiana University School of Medicine
Indianapolis, Indiana, 46202
Wichita Urology Group
Wichita, Kansas, 67226
BAMF Health
Grand Rapids, Michigan, 49503
Corewell Health
Grand Rapids, Michigan, 49503
Mayo Clinic- Rochester
Rochester, Minnesota, 55905
XCancer Omaha LLC
Omaha, Nebraska, 68130
Mount Sinai Doctors Urology Faculty Practice
New York, New York, 10029
Duke University Medical Center
Durham, North Carolina, 27710
Urologic Specialists
Tulsa, Oklahoma, 74146
Oregon Urology
Springfield, Oregon, 97477
Carolina Urologic Research Center
Myrtle Beach, South Carolina, 29572
Urology Associates of Nashville
Nashville, Tennessee, 37209
Urology Clinics of North Texas
Dallas, Texas, 75231
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-8896
The Urology Place
San Antonio, Texas, 78240
Intermountain Health
Murray, Utah, 84107
University of Wisconsin
Madison, Wisconsin, 53705